Anti-CD7 Antibody (GrisnilimAb)
Catalog No.
F1472
Anti-CD7 Antibody (GrisnilimAb)
Featured Products
Grisnilimab (WT1), an IgG2a monoclonal antibody (anti-CD7), is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab modulates the transcription of multiple target genes and may be involved in post-transcriptional processing of RNA.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.72 kDa
Dry ice
2367001-70-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Grisnilimab setaritox
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P09564
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD7
Please avoid freeze-thaw cycles.